Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Motixafortide acetate by BioLineRx for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Motixafortide acetate is under clinical development by BioLineRx and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According...
Data Insights
Motixafortide acetate by BioLineRx for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
Motixafortide acetate is under clinical development by BioLineRx and currently in Phase II for Esophageal Squamous Cell Carcinoma (ESCC). According...